About Eucalyptus
Eucalyptus is a Healthcare company based in Sydney (Australia) founded in 2018 by Charlie Gearside, Tim Doyle, and Benny Kleist, and was acquired by Hims in February 2026. Patient-centered healthcare solutions are delivered via a digital platform. It operates on a On-Demand Services, Subscription Services, and HealthTech model. Eucalyptus has raised $67.34 million across 3 funding rounds from investors including Hims, BOND and Blackbird Ventures. Its chief executive, as recorded, is Tim Doyle. Its website eucalyptus.health draws about 34 thousand monthly visits. Eucalyptus offers products and services including Kin, Pilot, Juniper, Compound, and Software. Its focus areas include Telehealth and Digital Clinics.
Company details
Healthcare solutions are delivered by Eucalyptus through a network of digital clinics focusing on telehealth. Various sectors including reproductive health, mens health, womens weight management, preventative care, and skincare are covered. Clinics such as Kin, Pilot, Juniper, Compound, and Software are operated to provide accessible, safe, and effective medical consultations and treatments. Chronic conditions are treated, preventative care is emphasized, and outdated systems are evolved to ensure patients receive quality care. Operations span multiple countries including Australia, the UK, Germany, and Japan, ensuring a broad reach for patient-centered services.
- Headquarters Sydney, Australia
- Founders Charlie Gearside, Tim Doyle, Benny Kleist
- Stage Acquired
- SectorsHealthcare
- Website category Business and Consumer Services · Business Services
- Email••••••••
- Phone•••• ••••
- Website eucalyptus.health
- Social LinkedIn Instagram
- Acquired by Hims (Feb 2026)
- Legal Name Eucalyptus
Products & Services of Eucalyptus
Eucalyptus offers a comprehensive portfolio of products and services, including Kin, Pilot, Juniper, Compound, and Software.
Reproductive care is provided for women’s health needs.
Men’s health issues are addressed through telehealth services.
Weight loss solutions are offered for women globally.
Preventative health programs are designed for men’s longevity.
Custom skincare treatments are delivered via telehealth.
Funding Insights of Eucalyptus
Eucalyptus has successfully raised a total of $67.34M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $42.92 million completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $67.34M
- Total Rounds 3
- Last Round Series C — $42.92M
- First Round $2M
(Oct 2019)
- Investors Count 7
All 3 funding rounds of Eucalyptus with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2022 | $42.92M | Series C | – | Bond Capital | |
| Jul 2021 | $22.42M | Series B | – | NewView Capital | |
| Oct 2019 | $2M | Seed | – | – |
8 investors in total: 8 institutional.
Investors in Eucalyptus
Eucalyptus has secured backing from 8 investors, including venture fund investors. Prominent investors backing the company include Hims, BOND and Blackbird Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments in multiple sectors are made by Bond Capital. | bondcap.com | San Francisco, United States | ||
Investments are made in seed, early, and later-stage tech companies. | blackbird.vc | Surry Hills, Australia | ||
Venture capital investment firm | nvc.vc | Burlingame, United States | ||
Investments in retail technology start-ups are made by Woolworths-backed W23. | w23.vc | Sydney, Australia | ||
Venture capital firm offering growth equity and credit for technology and healthcare companies. | one-ventures.com.au | |||
Athletic Ventures is formed by elite athletes investing in innovative companies. | athletic.vc | Australia | ||
Investments are directed toward early-stage tech startups by AirTree. | airtree.vc | Surry Hills, Australia | ||
Online platform offering telehealth services for men's wellness | 2017 | hims.com | San Francisco, United States |
Investor details for Eucalyptus
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Eucalyptus
4 people are tracked at Eucalyptus (4 in leadership).
| Name | Role | Group |
|---|---|---|
Charlie Gearside | Co-Founder | Leadership |
Tim Doyle | Co-Founder & CEO | Leadership |
Benny Kleist | Co-Founder | Leadership |
Simon Baume | COO | Leadership |
Complete people profiles for Eucalyptus
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Eucalyptus
4 dated milestones of Eucalyptus across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Eucalyptus is founded.
- Funding First funding round of $2.0M.
- Funding Latest funding round, Series C, of $42.9M.
- Exit Acquired by Hims.
Web traffic of Eucalyptus
The website of Eucalyptus (eucalyptus.health) receives about 33.9K visits a month and ranks #814,358 among all websites worldwide, #6,574 in Business Services.
- Monthly visits33.9K
▼ 2.9% vs previous month
- Unique visitors15.5K
per month
- Global rank#814,358
among all websites
- Category rank#6,574
Business and Consumer Services · Business Services
- Bounce rate40%
- Pages per visit2.3
- Average visit51 sec
- DevicesDesktop 49% · Mobile 51%
Websites whose visitors overlap most with Eucalyptus. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| startupdaily.net | 100% | #390,071 | View details | ||
| forbes.com.au | 96% | #148,989 | View details | ||
| capitalbrief.com | 68% | 680.7K | #329,001 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Eucalyptus
Complete news archive for Eucalyptus
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Eucalyptus
Eucalyptus was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Eucalyptus is headquartered in Sydney, Australia. It is registered at Sydney, New South Wales, Australia.
Tim Doyle is the CEO of Eucalyptus, as recorded in our data. They have also founded this company.
Eucalyptus is a funded company, having raised a total of $67.34M across 3 funding rounds to date. The company's 1st funding round was a Seed of $2M, raised on Oct 2019.
Annual revenue of Eucalyptus is $8.53K as on Dec 31, 2023.
Healthcare solutions are delivered by Eucalyptus through a network of digital clinics focusing on telehealth. Various sectors including reproductive health, mens health, womens weight management, preventative care, and skincare are covered. Clinics such as Kin, Pilot, Juniper, Compound, and Software are operated to provide accessible, safe, and effective medical consultations and treatments. Chronic conditions are treated, preventative care is emphasized, and outdated systems are evolved to ensure patients receive quality care. Operations span multiple countries including Australia, the UK, Germany, and Japan, ensuring a broad reach for patient-centered services.
Eucalyptus offers Kin, Pilot, Juniper, Compound, and Software.
Eucalyptus has 8 investors. Key investors include Hims, BOND, Blackbird Ventures, NewView Capital, and W23.
Eucalyptus operates through Eucalyptus.
Yes. Eucalyptus was acquired by Hims in February 2026.